BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Yuan D, Zhu D, Xu T, Huang A, Jiang L, Liu C, Qian H, Bu X. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p. J Ovarian Res 2021;14:109. [PMID: 34454554 DOI: 10.1186/s13048-021-00857-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hashemi M, Mirzaei S, Zandieh MA, Rezaei S, Amirabbas Kakavand, Dehghanpour A, Esmaeili N, Ghahremanzade A, Saebfar H, Heidari H, Salimimoghadam S, Taheriazam A, Entezari M, Ahn KS. Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Prog Biophys Mol Biol 2022:S0079-6107(22)00132-8. [PMID: 36584761 DOI: 10.1016/j.pbiomolbio.2022.12.004] [Reference Citation Analysis]
2 Wang X, Su P, Hao Q, Zhang X, Xia L, Zhang Y. A Chinese classical prescription Guizhi-Fuling Wan in treatment of ovarian cancer: An overview. Biomedicine & Pharmacotherapy 2022;153:113401. [DOI: 10.1016/j.biopha.2022.113401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Huang C, Cui H, Lang X, Zhao F, Wang F. An Integrative Analysis Revealing ZFHX4-AS1 as a Novel Prognostic Biomarker Correlated with Immune Infiltrates in Ovarian Cancer. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/9912732] [Reference Citation Analysis]
4 Wang G, Ding B, Sun L, Guo J, Wang S, Li W, Zhang Y, Lv J, Qiu W. Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma. Front Genet 2022;13:859544. [DOI: 10.3389/fgene.2022.859544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Feng S, Yin H, Zhang K, Shan M, Ji X, Luo S, Shen Y. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer. J Ovarian Res 2022;15. [DOI: 10.1186/s13048-022-00944-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]